Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Tirzepatide is another GLP-1 agonist that also targets glucose-dependent insulinotropic polypeptide (GIP), enhancing its effectiveness in weight loss and blood sugar control
It signals that shifting tactics may be necessary to continue losing weight
Steady dose escalation to higher doses than for glycaemic control are indicated if: BMI is 30 kg/m 2 , or BMI 27 to 30 kg/m 2 , and for the range 2730 kg/m 2 if there is one weight-related comorbidity (hypertension, dyslipidaemia, cardiovascular disease, obstructive sleep apnoea, prediabetes or T2D
Yeast infections are not associated with GLP-1 agonists like Ozempic
Gala GLP-1 connects patients with licensed healthcare providers who independently evaluate eligibility for treatment
Convenience and Ease of Use: Patches are convenient and easy to use
US$ 21.07
US$ 24.67
US$ 22.37
US$ 24.88
US$ 29.83
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
